Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 14,179 | 13,331 | 13,601 | 9,450 | 8,758 |
| Operating Income | -14,179 | -13,331 | -13,601 | -9,450 | -8,758 |
| Other Income | 86 | 92 | 39 | 3,270 | 3,263 |
| Pre-tax Income | -14,093 | -13,239 | -13,562 | -6,180 | -5,495 |
| Net Income Continuous | -14,093 | -13,239 | -13,562 | -6,180 | -5,495 |
| Net Income | $-14,093 | $-13,239 | $-13,562 | $-6,180 | $-5,495 |
| EPS Basic Total Ops | -552.55 | -1,570.57 | -3,213.21 | -6,426.43 | -21,111.11 |
| EPS Basic Continuous Ops | -551.41 | -1,342.24 | -2,902.62 | -4,250.32 | -21,102.45 |
| EPS Diluted Total Ops | -552.55 | -1,570.57 | -3,213.21 | -6,426.43 | -21,111.11 |
| EPS Diluted Continuous Ops | -551.41 | -1,342.24 | -2,902.62 | -4,250.32 | -21,102.45 |
| EPS Diluted Before Non-Recurring Items | -552.55 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-14,046 | $-11,573 | $-12,055 | $-9,093 | $-8,395 |